Division Chief - Professor of Pediatrics
Dr. Aldrovandi comes to us from CHLA where she has served as the Chief of the Division of Pediatric Infectious Diseases for the past two years and prior to that was a faculty member and conducted her research at the Saban Research Institute of CHLA. She is a translational physician-scientist and her expertise and innovative research has far-reaching collaborations. In 2014, Dr. Aldrovandi was part of a consortium that was awarded nearly $21 million by the National Institute of Allergy and Infectious Diseases for studies to advance the prevention and treatment of HIV and its complications for infants, children, adolescents, and pregnant/postpartum women. In addition to pediatric HIV, Dr. Aldrovandi’s research interests include the effects of breast milk on child health, and infections in immunocompromised children. Her laboratory has a broad-based program to investigate the transmission of HIV from mother to child, the pathogenesis of HIV in children and the protective value of breastfeeding. Dr. Aldrovandi received her MD degree from McGill University in Montreal, Canada, where she also did her pediatric residency. She completed her research fellowship in pediatric infectious diseases at UCLA.
Assistant Professor of Pediatrics
Dr. Adachi is a Assistant Professor in the Department of Pediatrics, Division of Infectious Diseases. She received her B.A. and M.A. from Stanford University and received her M.D. from UC San Diego School of Medicine in 2008. She completed her UCLA pediatrics internship and residency at UCLA in 2011 and later a three-year UCLA clinical fellowship in pediatric infectious diseases in 2015. She also completed an additional two-year postdoctoral pediatric infectious diseases research fellowship at UCLA focusing on perinatal infections from 2015-2017. She is board certified in both pediatrics (2011) and pediatric infectious diseases (2015). Her research interests for the past five years include global maternal-child health, particularly perinatal infections (CMV, Zika virus, and STIs including chlamydia, gonorrhea, syphilis). Her current research projects include investigating occult congenital infections in HIV-exposed infants, primarily from Brazil and South Africa, as well as various clinical research studies on outcomes of infants with in utero Zika-exposure in Brazil in collaboration with FIOUPIC (UC FIOCRUZ Perinatal Infections Collaborative).
Professor of Pediatrics
Dr. Bryson is a Distinguished Professor at the David Geffen School of Medicine at UCLA, and also a member of the UCLA AIDS Institute. She has significant experience in leading large multicenter clinical trials and networks and in developing clinical sites and laboratories. She is recognized as a national and international expert and leader in the field of HIV and perinatal transmission. Dr. Bryson has mentored numerous postdoctoral fellows and young faculty for successful careers in academic medicine. She was one of the original members of the Elizabeth Glaser Pediatric AIDS Foundation heath advisory board and helped start the foundation with Elizabeth Glaser, Dr. Richard Stiehm, and two co-founders. She is also widely recognized as an expert in the field of sexually transmitted diseases, specifically Herpes Simplex infections. Dr. Bryson has had a major role in developing the perinatal HIV scientific agenda for the Pediatric AIDS Clinical Trials Group (PACTG) as a longtime member of the perinatal HIV scientific advisory group, and as scientific chair for 3 years. She has made a strong commitment to international studies and to her collaborators in Brazil to help develop the necessary infrastructure to design, conduct and implement new approaches to prevent and treat HIV.
Professor of Pediatrics
Dr. Cherry has more than 45 years of experience in research, teaching and clinical practice in the fields of infectious diseases and epidemiology. His laboratory experience has been in virology, mycoplasmology and more recently, molecular microbiology relating to Bordetella species. His main research over the last 40 years has focused on vaccines and vaccine preventable diseases. The majority of his present looks at the epidemiology of Bordetella pertussis worldwide and its prevention by new vaccine strategies. He has been a frequent consultant to the Centers for Disease Control and Prevention, the Advisory Committee on Immunization Practices and vaccine manufacturers relating to vaccine preventable diseases. Dr. Cherry was Chief of the Division of Pediatric Infectious Diseases for 27 years. During that time, over 40 fellows in Infectious Diseases were trained and many have international positions (New Zealand, Thailand, Philippines, Korea, and Germany). Dr. Cherry is the author and co-author of over 600 publications, including The Textbook of Pediatric Infectious Diseases, which he is the editor, is now in press for the 7th edition. He has received numerous awards, including the Distinguished Physician Award from the Pediatric Infectious Diseases Society.
Annabelle de St. Maurice, MD, MPH
Assistant Professor of Pediatrics
Dr. de St. Maurice is an Assistant Professor of Pediatrics in the Division of Infectious Diseases and leads the Pediatric Infection Control and Antibiotic Stewardship Programs at UCLA. She obtained her medical degree at the University of Rochester and completed her Pediatrics residency at Children’s Hospital of Pittsburgh of UPMC. After residency, Dr. de St. Maurice went to Vanderbilt University where she completed a pediatric infectious disease fellowship and earned a Masters in Public Health. After fellowship she joined the Epidemic Intelligence Service at the CDC where she studied the epidemiology of viral hemorrhagic fevers. Her research and clinical interests are focused on mitigating the spread and severity of infectious diseases through vaccines and infection control practices. She has studied the impact of pneumococcal vaccine on invasive pneumococcal disease rates, risk factors for hantavirus pulmonary syndrome, epidemiology of Rift Valley fever disease, and sequelae of Ebola disease in survivors. In her current role, Dr. de St. Maurice will continue studying the spread of infections and multi-drug resistant organisms in the community and in the hospital setting.
Clinical Professor of Pediatrics
Dr. Deville is a Clinical Professor of Pediatrics in the Division of Infectious Diseases at the David Geffen School of Medicine at UCLA and provides primary care for patients in the Care-4-Families Clinic at UCLA. Dr. Deville obtained his MD from Universidad Peruana Cayetano Heredia, Lima, Peru. He also completed a one year Tropical Medicine fellowship at the Alexander Von Humboldt Tropical Medicine Institute in Lima, Peru, a pediatric internship at the Cayetano Heredia University Hospital in Lima, Peru, and subsequently completed his pediatric residency as well as chief residency at State University of New York Downstate Medical Center. Dr. Deville has been at UCLA since 1992 where he completed research and clinical Pediatric Infectious Disease fellowships, including a one year epidemiology fellowship at the UCLA Center for Vaccine Research. Dr. Deville is Vice-Chair of the Advisory Commission in Childhood Vaccines for the Health Resources and Services Administration of the US Department of Health and Human Services. He is also a member of the National Advisory Committee of the National Hispanic Medical Association and serves as a reviewer for 13 leading medical journals. Dr. Deville's main areas of research have been in childhood vaccines, immunology and morbidity of pediatric HIV infection, and neonatal and pediatric gram-positive infections. He was one of the leaders in the study and development of linezolid for treatment of resistant gram-positive bacterial infections in children.
Professor of Pediatrics
Dr. Paul Krogstad attended UCLA and received his Bachelor of Science in Cybernetics and a Master's Degree in Engineering. After leaving Los Angeles, he attended the Tulane University School of Medicine in New Orleans, Louisiana, where he also completed his training in Pediatrics.
He trained as a specialist in Pediatric Infectious Diseases at the University of Washington in Seattle, then returned to UCLA for additional postdoctoral training in human retrovirology. He joined the UCLA faculty in 1992 and is now a Professor in the departments of Pediatrics and Pharmacology, and serves as the Director of the Fellowship Program in Pediatric Infectious Diseases.
Dr. Krogstad's laboratory focuses on molecular virology and the pathogenesis of viral diseases. His studies of HIV pathogenesis currently include evaluation of the impact of HIV on T cell production and immunological ontogeny in HIV infected children and adolescents. His laboratory research also includes molecular approaches to the identification of cellular factors involved in coxsackievirus replication and the immunological and viral contributions to the pathogenesis of enteroviral myocarditis. In addition, he has led and collaborated in several studies of new drugs for the treatment of HIV and enteroviral infection.
Professor of Pediatrics
Dr. Lehman, MD, is Professor of Pediatrics at the David Geffen School of Medicine at the University of California, Los Angeles. She received her undergraduate degree from Stanford University and MD from UCLA School of Medicine. She completed her pediatric residency at Children’s Hospital of Los Angeles and pediatric infectious diseases training at UCSF. She serves as the Associate Vice Chair for education for the department of Pediatrics and in this role oversees the pediatric clerkship for third-year medical students, and pediatric electives for fourth year students. She serves as an Assistant Dean for Student Affairs at the David Geffen School of Medicine in their longitudinal advising program leading a society of 180 students. She is the recipient of several teaching awards and has created a popular pediatric infectious diseases curriculum for rotating medical students and residents. She recently completed a month long faculty development course at Stanford University, training her to be a facilitator for the 14 hour clinical teaching course. Her special interests include congenital infections and medical education. She is on the editorial board of NEJM Journal Watch Pediatrics and Adolescent Medicine and a senior deputy editor of NEJM Knowledge Plus, an online adaptive learning program.
Clinical Professor of Pediatrics
Dr. Nielsen is a Clinical Professor of Pediatrics in the Division of Infectious Diseases at the David Geffen School of Medicine at UCLA and has been a member of the UCLA faculty since 1996. She has been the Co-PI of an international collaborative effort funded by the NIH for the conduct of HIV prevention and treatment trials in Brazil for the last seven years. Dr. Nielsen is an elected member of the Scientific Oversight Committee of the NIH funded pediatric network (IMPAACT) leadership group. She is also a consultant for the Italian based DREAM program which implements treatment of over 40,000 HIV-infected individuals in six African countries. She is an attending physician for Pediatric Infectious Diseases and for the CARE-4-Families Clinic at UCLA. Dr. Nielsen has a Masters Degree in epidemiology from UCLA's School of Public Health. She obtained her MD from the Universidade do Rio de Janeiro, Brazil and completed pediatric residency training at the Hospital dos Servidores also in Rio. She has been at UCLA since 1991 where she completed both research and clinical fellowships in Pediatric Infectious Diseases. Dr. Nielsen's main area of research has been pediatric/perinatal HIV infection. She has conducted studies in the pathogenesis of transmission of HIV, studies of virologic and immunologic markers of pediatric long term survival in HIV infection, treatment trials and PK studies of protease inhibitors in children, development of biological assays for diagnostics and monitoring of viral resistance, and immunological studies.
Assistant Professor of Pediatrics
Dr. Yeganeh is a Assistant Professor in the Department of Pediatrics, Division of Infectious Disease at the David Geffen School of Medicine at UCLA. She obtained her medical degree at University of Washington School of Medicine, her Masters of Public Health at Johns Hopkins School of Public Health. Dr. Yeganeh has been at UCLA since 2005, completing her training in pediatrics and infectious diseases. Her current research focuses on preventing transmission of HIV to infants through the implementation of TRIPAI - an initiative focused on offering rapid HIV and STD testing to partners of pregnant women. Her research is currently taking place at collaborating research sites in Porto Alegre, Brazil. Her future research will focus on expanding TRIPAI intervention by utilizing other rapid tests (Syphilis, Hepatitis B, C) to detect sexually transmitted disease in the father before he could transmit infection to the mother and infant. She is a former FRAME trainee, which allowed her to use innovative technologies, including audio computer-assisted survey interviews to detect more sensitized behaviors during TRIPAI. Through her research, she has created close collaborations with members of the School of Medicine, the School of Public Health, and the School of Engineering, and will continue to perform research with new fellows both at UCLA and in Brazil.
